Get the Stockscreener App
2.40
4.00%
-0.10
Arca Biopharma Inc stock is traded at $2.40, with a volume of 289.44K.
It is down -4.00% in the last 24 hours and up +0.00% over the past month.
ARCA biopharma Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to the development and commercialization of targeted therapies for cardiovascular diseases. The company's product candidates are rNAPc2 as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro for the treatment of atrial fibrillation, or AF, in patients with chronic heart failure, or HF. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy.
See More
Previous Close:
$2.50
Open:
$2.35
24h Volume:
289.44K
Relative Volume:
2.00
Market Cap:
$34.82M
Revenue:
-
Net Income/Loss:
$-5.34M
P/E Ratio:
-6.4865
EPS:
-0.37
Net Cash Flow:
$-5.01M
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
-30.23%
1Y Performance:
+42.86%
1-Day Range:
$2.22
$2.47
1-Week Range:
$2.22
$2.47
52-Week Range:
$1.56
$4.49
Arca Biopharma Inc Stock (ABIO) Company Profile
Name
Arca Biopharma Inc
Sector
Industry
Phone
(720) 940-2200
Address
10170 CHURCH RANCH WAY, WESTMINSTER, CO
Compare ABIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABIO
Arca Biopharma Inc
|
2.40 | 34.82M | 0 | -5.34M | -5.01M | -0.37 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.56 | 105.47B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
696.88 | 76.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
656.26 | 39.24B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
237.98 | 30.69B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
122.85 | 29.45B | 3.30B | -501.07M | 1.03B | -2.1146 |
Arca Biopharma Inc Stock (ABIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-11-24 | Initiated | Stifel | Buy |
| Oct-07-24 | Initiated | H.C. Wainwright | Buy |
| Sep-17-24 | Initiated | Leerink Partners | Outperform |
| Sep-16-24 | Initiated | TD Cowen | Buy |
| Sep-13-24 | Initiated | Jefferies | Buy |
| Feb-27-18 | Initiated | Ascendiant Capital Markets | Buy |
| Oct-09-13 | Initiated | Dawson James | Buy |
View All
Arca Biopharma Inc Stock (ABIO) Latest News
Oruka Therapeutics (NASDAQ:ORKA) Reaches New 52-Week LowShould You Sell? - MarketBeat
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Average Recommendation of “Buy” from Brokerages - Defense World
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives $43.17 Consensus Target Price from Analysts - MarketBeat
Oruka Therapeutics (NASDAQ:ORKA) Trading Down 3.2%Time to Sell? - MarketBeat
Critical Contrast: BG Medicine (OTCMKTS:BGMD) & Oruka Therapeutics (NASDAQ:ORKA) - Defense World
Oruka Therapeutics (NASDAQ:ORKA) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
Franklin Resources Inc. Makes New Investment in Oruka Therapeutics, Inc. (NASDAQ:ORKA) - MarketBeat
Oruka Therapeutics' (ORKA) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
Oruka Therapeutics (NASDAQ:ORKA) Shares Down 4.7%Should You Sell? - MarketBeat
Wellington Management Group LLP Acquires New Position in Oruka Therapeutics, Inc. (NASDAQ:ORKA) - Defense World
Wellington Management Group LLP Makes New $2.01 Million Investment in Oruka Therapeutics, Inc. (NASDAQ:ORKA) - MarketBeat
Oruka Therapeutics (NASDAQ:ORKA) Sees Large Volume IncreaseShould You Buy? - MarketBeat
The Manufacturers Life Insurance Company Acquires New Holdings in Oruka Therapeutics, Inc. (NASDAQ:ORKA) - Defense World
The Manufacturers Life Insurance Company Invests $1.04 Million in Oruka Therapeutics, Inc. (NASDAQ:ORKA) - MarketBeat
Frazier Life Sciences Management L.P. Purchases New Stake in Oruka Therapeutics, Inc. (NASDAQ:ORKA) - MarketBeat
Janus Henderson Group PLC Acquires Shares of 236,116 Oruka Therapeutics, Inc. (NASDAQ:ORKA) - MarketBeat
Point72 Asset Management L.P. Acquires Shares of 482,330 Oruka Therapeutics, Inc. (NASDAQ:ORKA) - MarketBeat
RTW Investments LP Takes $45.36 Million Position in Oruka Therapeutics, Inc. (NASDAQ:ORKA) - MarketBeat
Redmile Group LLC Acquires Shares of 411,728 Oruka Therapeutics, Inc. (NASDAQ:ORKA) - MarketBeat
Fmr LLC Buys Shares of 4,682,300 Oruka Therapeutics, Inc. (NASDAQ:ORKA) - MarketBeat
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Given Average Rating of “Buy” by Brokerages - Defense World
Braidwell LP Acquires New Holdings in Oruka Therapeutics, Inc. (NASDAQ:ORKA) - MarketBeat
Oruka Therapeutics (NASDAQ:ORKA) Trading Up 7.4%Here's Why - MarketBeat
Great Point Partners LLC Takes $12.61 Million Position in Oruka Therapeutics, Inc. (NASDAQ:ORKA) - MarketBeat
HC Wainwright Analysts Decrease Earnings Estimates for ORKA - MarketBeat
ARCA BIOPHARMA, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) - Marketscreener.com
Oruka Therapeutics (NASDAQ:ORKA) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Oruka Therapeutics gains approval for preferred stock conversion - Investing.com UK
Oruka Therapeutics adjusts financials post-merger By Investing.com - Investing.com Canada
Oruka Therapeutics adjusts financials post-merger - Investing.com
FMR LLC Acquires New Stake in ARCA biopharma Inc - Yahoo Finance
Manuel Alba Sells 37,000 Shares of Astera Labs, Inc. (NASDAQ:ALAB) Stock - Defense World
Great Point Partners LLC Increases Stake in Arcellx, Inc. (NASDAQ:ACLX) - Defense World
38,761 Shares in Arcus Biosciences, Inc. (NYSE:RCUS) Purchased by XTX Topco Ltd - Defense World
Astera Labs, Inc. (NASDAQ:ALAB) Shares Sold by American Century Companies Inc. - Defense World
Assicurazioni Generali (OTCMKTS:ARZGY) Shares Up 0.1% - Defense World
Investing in Aclaris Therapeutics Inc (ACRS) Is Getting More Attractive - Knox Daily
Integral Health Asset Management LLC Buys 20,000 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World
ProShare Advisors LLC Sells 79,195 Shares of AstraZeneca PLC (NASDAQ:AZN) - Defense World
Discovery Capital Management LLC CT Reduces Stake in Astera Labs, Inc. (NASDAQ:ALAB) - Defense World
AstraZeneca PLC (NASDAQ:AZN) Stock Position Lifted by Massachusetts Financial Services Co. MA - Defense World
Rhumbline Advisers Takes $1.01 Million Position in Astera Labs, Inc. (NASDAQ:ALAB) - Defense World
Arcus Biosciences Looks Compelling Ahead Of Key Clinical Oncology Milestones - Seeking Alpha
AstraZeneca PLC (NASDAQ:AZN) Stock Position Raised by Sei Investments Co. - Defense World
Itau Unibanco Holding S.A. Lowers Stock Holdings in AstraZeneca PLC (NASDAQ:AZN) - Defense World
AstraZeneca PLC (NASDAQ:AZN) Shares Acquired by Edge Capital Group LLC - Defense World
Blair William & Co. IL Sells 12,528 Shares of Ares Capital Co. (NASDAQ:ARCC) - Defense World
Mount Yale Investment Advisors LLC Raises Stock Holdings in AstraZeneca PLC (NASDAQ:AZN) - Defense World
Astera Labs, Inc. (NASDAQ:ALAB) Shares Bought by Massachusetts Financial Services Co. MA - Defense World
AstraZeneca PLC (NASDAQ:AZN) Shares Purchased by Legacy Financial Advisors Inc. - Defense World
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives $41.25 Average PT from Analysts - Defense World
Arca Biopharma Inc Stock (ABIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Arca Biopharma Inc Stock (ABIO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 10% Owner |
Jul 24 '24 |
Buy |
3.20 |
189,856 |
606,873 |
2,081,168 |
| JANUS HENDERSON GROUP PLC | 10% Owner |
Jul 25 '24 |
Buy |
3.05 |
30,227 |
92,292 |
2,111,395 |
| JANUS HENDERSON GROUP PLC | 10% Owner |
Jul 03 '24 |
Buy |
3.55 |
166,042 |
589,565 |
1,648,577 |
| JANUS HENDERSON GROUP PLC | 10% Owner |
Jul 11 '24 |
Buy |
3.45 |
94,537 |
326,304 |
1,891,312 |
| JANUS HENDERSON GROUP PLC | 10% Owner |
Jul 10 '24 |
Buy |
3.46 |
55,463 |
192,130 |
1,796,775 |
| JANUS HENDERSON GROUP PLC | 10% Owner |
Jul 08 '24 |
Buy |
3.46 |
47,492 |
164,190 |
1,724,395 |
| JANUS HENDERSON GROUP PLC | 10% Owner |
Jul 05 '24 |
Buy |
3.43 |
28,326 |
97,065 |
1,676,903 |
| JANUS HENDERSON GROUP PLC | 10% Owner |
Jul 09 '24 |
Buy |
3.43 |
16,917 |
58,091 |
1,741,312 |
3.54%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):